| Primary |
| Product Used For Unknown Indication |
54.3% |
| Muscle Spasms |
9.6% |
| Upper Respiratory Tract Infection |
4.3% |
| Muscle Relaxant Therapy |
3.2% |
| Muscle Spasticity |
3.2% |
| Osteoporosis |
3.2% |
| Arthralgia |
2.1% |
| Back Pain |
2.1% |
| Drooling |
2.1% |
| Joint Contracture |
2.1% |
| Osteoarthritis |
2.1% |
| Pain |
2.1% |
| Sleep Disorder |
2.1% |
| Arthritis |
1.1% |
| Deep Vein Thrombosis |
1.1% |
| Dental Care |
1.1% |
| Factor V Deficiency |
1.1% |
| Fibromyalgia |
1.1% |
| Hypertension |
1.1% |
| Hypothyroidism |
1.1% |
|
| Completed Suicide |
15.2% |
| Torsade De Pointes |
12.1% |
| Unresponsive To Stimuli |
9.1% |
| Drug Interaction |
6.1% |
| Gastritis |
6.1% |
| Syncope |
6.1% |
| Vomiting |
6.1% |
| Blood Pressure Decreased |
3.0% |
| Bradycardia |
3.0% |
| Death |
3.0% |
| Drug Abuse |
3.0% |
| Drug Ineffective |
3.0% |
| Epiglottic Oedema |
3.0% |
| Hallucination |
3.0% |
| Hepatotoxicity |
3.0% |
| Inflammation |
3.0% |
| Labelled Drug-drug Interaction Medication Error |
3.0% |
| Laryngeal Oedema |
3.0% |
| Memory Impairment |
3.0% |
| Product Quality Issue |
3.0% |
|
| Secondary |
| Product Used For Unknown Indication |
63.6% |
| Suicide Attempt |
9.1% |
| Overdose |
6.4% |
| Pain |
4.1% |
| Muscle Spasticity |
2.5% |
| Multiple Sclerosis |
1.8% |
| Fibromyalgia |
1.6% |
| Drug Use For Unknown Indication |
1.4% |
| Muscle Spasms |
1.4% |
| Rheumatoid Arthritis |
1.3% |
| Arthralgia |
1.1% |
| Depression |
0.9% |
| Hypertension |
0.7% |
| Sleep Disorder |
0.7% |
| Systemic Lupus Erythematosus |
0.7% |
| Anxiety |
0.5% |
| Arthritis |
0.5% |
| Asthma |
0.5% |
| Back Pain |
0.5% |
| Breakthrough Pain |
0.5% |
|
| Completed Suicide |
17.6% |
| Toxicity To Various Agents |
16.0% |
| Respiratory Arrest |
10.1% |
| Poisoning |
8.4% |
| Death |
4.2% |
| Drug Hypersensitivity |
4.2% |
| Serotonin Syndrome |
4.2% |
| Somnolence |
4.2% |
| Unresponsive To Stimuli |
4.2% |
| Drug Abuse |
3.4% |
| Pneumonia Aspiration |
3.4% |
| Cardio-respiratory Arrest |
2.5% |
| Pain |
2.5% |
| Renal Failure Acute |
2.5% |
| Therapeutic Response Decreased |
2.5% |
| Torsade De Pointes |
2.5% |
| Vomiting |
2.5% |
| Muscle Spasms |
1.7% |
| Muscular Weakness |
1.7% |
| Suicide Attempt |
1.7% |
|
| Concomitant |
| Product Used For Unknown Indication |
36.9% |
| Pain |
8.9% |
| Multiple Sclerosis |
8.3% |
| Depression |
4.4% |
| Gastrooesophageal Reflux Disease |
4.3% |
| Anxiety |
3.6% |
| Hypertension |
3.6% |
| Muscle Spasms |
3.5% |
| Fibromyalgia |
3.2% |
| Asthma |
2.9% |
| Back Pain |
2.6% |
| Migraine |
2.6% |
| Rheumatoid Arthritis |
2.4% |
| Muscle Relaxant Therapy |
2.4% |
| Insomnia |
2.3% |
| Neuralgia |
1.7% |
| Sleep Disorder |
1.7% |
| Diabetes Mellitus |
1.6% |
| Muscle Spasticity |
1.5% |
| Arthritis |
1.4% |
|
| Vomiting |
14.0% |
| Drug Ineffective |
10.6% |
| Weight Decreased |
7.2% |
| Pain |
6.2% |
| Urinary Tract Infection |
5.9% |
| Pulmonary Embolism |
5.6% |
| Wrong Technique In Drug Usage Process |
5.6% |
| Nausea |
5.3% |
| Weight Increased |
4.7% |
| Pain In Extremity |
4.0% |
| Vision Blurred |
4.0% |
| Vitamin D Deficiency |
3.4% |
| Muscle Spasms |
3.1% |
| Sinusitis |
3.1% |
| Somnolence |
3.1% |
| Visual Impairment |
3.1% |
| Suicidal Ideation |
2.8% |
| Tremor |
2.8% |
| Type 2 Diabetes Mellitus |
2.8% |
| Fall |
2.5% |
|
| Interacting |
| Product Used For Unknown Indication |
31.6% |
| Convulsion |
21.1% |
| Back Pain |
10.5% |
| Pain |
10.5% |
| Arthralgia |
5.3% |
| Multiple Sclerosis |
5.3% |
| Osteoarthritis |
5.3% |
| Pyelonephritis |
5.3% |
| Sepsis |
5.3% |
|
| Suicidal Ideation |
42.9% |
| Drug Interaction |
28.6% |
| Bradycardia |
14.3% |
| Hypoxia |
14.3% |
|
